Cerus Corporation (CERS) support and resistance · rev $201.3M
Cerus Corporation (CERS) is a medical devices company listed on US.
This page maps Cerus Corporation (CERS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
CERS currently screens at market cap $294.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CERS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CERS quote page for the session range and the stock page for the full model.
Not investment advice.